Stereoselective synthesis of 2,6-disubstituted 3-piperidinols: Application to the expedient synthesis of (+)-julifloridine

Organic Letters

Volumn 7, Issue 13, 2005, Pages 2747-2750

  Lemire, Alexandre ^a   Charette, André B ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; JULIFLORIDINE; PIPERIDINE DERIVATIVE; PYRIDINIUM DERIVATIVE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; STEREOISOMERISM; SYNTHESIS;

ALKALOIDS; MOLECULAR STRUCTURE; PIPERIDINES; PYRIDINIUM COMPOUNDS; STEREOISOMERISM;

EID: 27644547805     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol051022z     Document Type: Article

References (69)

1. For recent reviews on the stereoselective synthesis of piperidines, see: (a) Buffat, M. G. P. Tetrahedron 2004, 60, 1701-1729.
2. (b) Felpin, F.-X.; Lebreton, J. Eur. J. Org. Chem. 2003, 3693-3712.
3. (c) Weintraub, P. M.; Sabol, J. S.; Kane, J. M.; Borcherding, D. R. Tetrahedron 2003, 59, 2953-2989.
4. For recent examples: (a) Wang, X.; Dong, Y.; Sun, J.; Xu, X.; Li, R.; Hu, Y. J. Org. Chem. 2005, 70, 1897-1900.
5. (b) Toure, B. B.; Hall, D. G. Angew. Chem., Int. Ed. 2004, 43, 2001-2004.
6. (c) Ichikawa, E.; Suzuki, M.; Yabu, K.; Albert, M.; Kanai, M.; Shibasaki, M. J. Am. Chem. Soc. 2004, 126, 11808-11809.
7. (d) Shintani, R.; Tokunaga, N.; Doi, H.; Hayashi, T. J. Am. Chem. Soc. 2004, 126, 6240-6241.
8. See also: (e) Comins, D. L.; Goehring, R. R.; Joseph, S. P.; O'Connor, S. J. Org. Chem. 1990, 55, 2574-2576.
9. (f) Génisson, Y.; Marazano, C.; Das, B. C. J. Org. Chem. 1993, 58, 2052-2057.
10. (a) Strunz, G. M.; Findlay, J. A. In The Alkaloids; Brossi, A., Ed.; Academic Press: New York, 1985; Vol. 26, Chapter 3.
11. (b) Astudillo S. L.; Jürgens, S. K.; Schmeda-Hirschmann, G.; Griffith, G. A.; Holt, D. J.; Jenkins, P. R. Planta Med. 1999, 65, 161-162.
12. (c) Melhaoui, A.; Belouali, H. J. Ethnopharm. 1998, 62, 67-71.
13. (d) Bolzani, V. S.; Gunatilaka, A. A. L.; Kingston, D. G. I. Tetrahedron 1995, 51, 5929-5934.
14. (e) Hootelé, C.; Colau, B.; Halin, F. Tetrahedron Lett. 1980, 21, 5061-5062.
15. (f) Baliah, V.; Jeyaraman, R.; Chandrasekaran, L. Chem. Rev. 1983, 83, 379-423.
16. For recent syntheses, see: (a) Cassidy, M. P.; Padwa, A. Org. Lett. 2004, 6, 4029-4031.
17. (b) Randl, S.; Blechert, S. Tetrahedron Lett. 2004, 45, 1167-1169.
18. (c) Chavan, S. P.; Praveen, C. Tetrahedron Lett. 2004, 45, 421-423.
19. (d) Jourdant, A.; Zhu, J. Heterocycles 2004, 64, 249-259.
20. Liu, L.-X.; Ruan, Y.-P.; Guo, Z.-Q.; Huang, P.-Q. J. Org. Chem. 2004, 69, 6001-6009.
21. (e) Wang, Q.; Sasaki, N. A. J. Org. Chem. 2004, 69, 4767-4773.
22. (f) Makabe, H.; Kong, L. K.; Hirota, M. Org. Lett. 2003, 5, 27-29.
23. (g) Sato, T.; Aoyagi, S.; Kibayashi, C. Org. Lett. 2003, 5, 3839-3842.
24. (h) Lee, H. K.; Chun, J. S.; Pak, C. S. Tetrahedron 2003, 59, 6445-6454.
25. (i) Ma, D.; Ma, N. Tetrahedron Lett. 2003, 44, 3963-3965.
26. (j) Davis, F. A.; Rao, A.; Carroll, P. J. Org. Lett. 2003, 5, 3855-3857.
27. (k) Sengupta, S.; Mondal, S. Tetrahedron 2002, 58, 7983-7986.
28. (l) Singh, R.; Ghosh, S. K. Tetrahedron Lett. 2002, 43, 7711-7715.
29. (m) Toyooka, N.; Nemoto, H. Drugs Future 2002, 27, 143-158.
30. (n) Bailey, P. D.; Smith, P. D.; Morgan, K. M.; Rosair, G. M. Tetrahedron, Lett. 2002, 43, 1071-1074.
31. (o) Comins, D. L.; Sandelier, M. J.; Grillo, T. A. J. Org. Chem. 2001, 66, 6829-6832.
32. (p) Enders, D.; Kirchhoff, J. H. Synthesis 2000, 2099-2105.
33. (q) Agami, C.; Couty, F.; Lam, H.; Mathieu, H. Tetrahedron 1998, 54, 8783-8796.
34. (r) Kiguchi, T.; Shirakawa, M.; Honda, R.; Ninomiya, I.; Naito, T. Tetrahedron 1998, 54, 15589-15606 and references therein.
35. (a) Charette, A. B.; Grenon, M.; Lemire, A.; Pourashraf, M.; Martel, J. J. Am. Chem. Soc. 2001, 123, 11829-11830.
36. (b) Legault, C.; Charette, A. B. J. Am. Chem. Soc. 2003, 125, 6360-6361.
37. (c) Lemire, A.; Grenon, M.; Pourashraf, M.; Charette, A. B. Org. Lett. 2004, 6, 3517-3520.
38. (d) Lemire, A.; Beaudoin, D.; Grenon, M.; Charette, A. B. J. Org. Chem. 2005, 70, 2368-2371.
39. (a) Comins, D. L.; Joseph, S. P. Advances in Nitrogen Heterocycles; Moody, C. J., Ed.; JAI Press, Inc.: Greenwich, CT, 1996; Vol. 2, pp 251-294.
40. (b) Hoffmann, H. R. Chem. Rev. 1989, 89, 1841-1860.
41. (c) Johnson, F. Chem. Rev. 1968, 68, 375-413.
42. For a review on stereocontrolled additions to di- and tetrahydropyridines, see: (a) Kumar, R.; Chandra, R. Adv. Heterocycl. Chem. 2001, 78, 269-313.
43. For a review on dihydropyridines, see: (b) Lavilla, R. J. Chem. Soc., Perkin Trans. 1 2002, 1141-1156.
44. For stereoselective synthesis of 1,2,5,6-tetrahydropyridines, see: (c) Huang, H.; Spande, T. F.; Panek, J. S. J. Am. Chem. Soc. 2003, 125, 626-627.
45. (d) Felpin, F.-X.; Lebreton, J. Curr. Org. Synth. 2004, 1, 83-109.
46. For 2,6-disubstituted 1,2-dihydropyridines, see: (a) Comins, D. L.; Weglarz, M. A. J. Org. Chem. 1991, 56, 2506-2512.
47. (b) Yamaguchi, R.; Nakazono, Y.; Matsuki, T.; Hata, E.-i.; Kawanisi, M. Bull Chem. Soc. Jpn. 1987, 60, 215-222.
48. For 3,5-disubstituted dihydropyridines, see: (c) Comins, D. L.; Williams, A. L. Org. Lett. 2001, 3, 3217-3220.
49. For disubstituted 1,2-dihydropyridines substituted with an electron-withdrawing group, see: (a) Kita, Y.; Maekawa, H.; Yamasaki, Y.; Nishiguchi, I. Tetrahedron 2001, 57, 2095-2102.
50. (b) Lavilla, R.; Gotsens, T.; Gullón, F.; Bosch, J. Tetrahedron 1994, 50, 5233-5244.
51. (c) Naito, T.; Lida, N.; Ninomiya, I. J. Chem. Soc., Perkin Trans. 1 1986, 99-104.
52. Camps, F.; Coll, J.; Messeauer, A.; Pujol, F. J. Org. Chem. 1982, 47, 5402-5404. 2-Propanol was used as a nucleophile since methanol is described to be incompatible with this epoxidation procedure. Furthermore, both nucleophiles were shown to cleanly react with 12 (with DMDO, see Table 2).
53. This KF-MCPBA complex was shown to cleanly epoxidize diverse glucals; see: Bellucci, G.; Catelani, G.; Chiappe, C.; D'Andrea, F. Tetrahedron Lett. 1994, 35, 8433-8436.
54. Cis product is the kinetic product since treatment of 13a with TFA in EtOH for 76 h led to the 2,3-trans-ethanol adduct in 74% yield.
55. Blaauw and co-workers reported an oxone-mediated epoxidation-methanol opening of a related tetrahydropyridine, but the cis-trans ratio was not specified. See: Botman, P. N. M.; Dommerholt, F. J.; de Gelder, R.; Broxterman, Q. B.; Schoemaker, H. E.; Rutjes, F. P. J. T.; Blaauw, R. H. Org. Lett. 2004, 6, 4941-4944.
56. Related cis stereoselective pyridinone epoxide intramolecular opening with an alcohol, leading to an oxazolopiperidine, has been reported: Amat, M.; Llor, N.; Huguet, M.; Molins, E.; Espinosa, E.; Bosch, J. Org. Lett. 2001, 3, 3257-3260.
57. Asymmetric epoxidation of unsubstituted N-tosyl-1,4,5,6- tetrahydropyridirines has been reported, but the yields or enantioselectivities are modest; see: Sunose, M.; Anderson, K. M.; Orpen, A. G.; Gallagher, T.; Macdonald, S. J. F. Tetrahedron Lett. 1998, 39, 8885-8888.
58. DMDO and MCPBA epoxidation of unsubstituted N-ethylcarbamoyl-1,4,5,6- tetrahydropyridines has been reported, but the cis-trans selectivity of the nucleophilic substitution of the epoxide is low (1:1.5 to 1:1.8), see: (a) Sugisaki, C. H.; Carroll, P. J.; Correia, C. R. D. Tetrahedron Lett. 1998, 39, 3413-3416.
59. (b) Burgess, L. E.; Gross, E. K. M.; Jurka, J. Tetrahedron Lett. 1996, 37, 3255-3258.
60. (a) Treatment of N-acetyl-1,4,5,6-tetrahydropyridines with peroxybenzoic acid gave N-acetyl-2-benzoyloxy-3-hydroxypiperidine, but the cis-trans ratio was not specified; see: Masamune, T.; Hayashi, H.; Takasugi, M.; Fukuoka, S. J. Org. Chem. 1972, 57, 2343-2345.
61. (b) A related MCPBA epoxidation of N-methylcarbamoyl-1,4-dihydropyridine has been shown to give the corresponding addition products with trans relative stereochemistry. However, use of DMDO afforded a dioxane dimer from dimerization of the opened epoxide; see: Lavilla, R.; Barón, X.; Coll, O.; Gullón, F.; Masdeu, C.; Bosch, J. J. Org. Chem. 1998, 63, 10001-10005.
62. For a related cis stereoselective glycal epoxide opening using organozinc triflate or organozinc chloride, see: Xue, S.; Han, K.-Z.; Guo, Q.-X. Synlett 2003, 870-872.
63. Use of organoaluminum and organoboron reagents, see: Allwein, S. P.; Cox, J. M.; Howard, B. E.; Johnson, H. W. B.; Rainier, J. D. Tetrahedron 2002, 58, 1997-2009.
64. Use of sodium thiophenolate, see: Marzabadi, C. H.; Spilling, C. D. J. Org. Chem. 1993, 58, 3761-3766.
65. 4 semipinacol-type rearrangement of 2-cycloalkanol-substituted N-tosyl-1,4,5,6-tetrahydropyridines, see: Dake, G. R.; Fenster, M. D. B.; Fleury, M.; Patrick, B. O. J. Org. Chem. 2004, 69, 5676-5683.
66. Isolation: (a) Ahmad, V. U.; Basha, A.; Haque, W. Z. Naturforsch., B: Anorg. Chem., Org. Chem. 1978, 33B, 347-348.
67. (b) Ahmad, V. U.; Usmanghani, K.; Najmus-Saqib, Q. Sci. Pharm. 1979, 47, 333-334.
68. Absolute configuration determination: (c) Ahmad, V. U.; Qazi, S. Z. Naturforsch., B: Anorg. Chem., Org. Chem. 1983, 38B, 347-348.
69. For asymmetric synthesis of 1, see ref 4r. For racemic synthesis, see: Paterne, M.; Brown, É. C. R. Séances Acad. Sci., Ser. 2 1983, 296, 433-434.